On May 20, Yili Group held a global product launch event in Hong Kong, introducing three new infant formula products under its Pro-Kido brand: Aronurish, Tofer Eptide, and Tofer Minno.

At the launch event, Yili announced a strategic partnership with Mannings, the largest health and beauty retail chain in Hong Kong. As part of the collaboration, Aronurish will be available in over 200 Mannings stores across Hong Kong, as well as through online channels.

Product Launch Event in Hong Kong. [Photo provided to chinadaily.com.cn]

A key highlight was the release of the 2025 Breast Milk Research Key Findings Report, showcasing 13 major scientific achievements by Yili in areas such as human milk oligosaccharides (HMOs) and infant gut microbiota. These breakthroughs demonstrate the leading role of Chinese enterprises in global research on maternal and infant nutrition.

HMOs are considered one of the hottest frontiers in breast milk research, with Yili already having been granted 28 invention patents in this field.

The newly launched Aronurish is produced at Yili's Infant Formula Manufacturing Facility at Yili Future Intelligence & Health Valley in Hohhot. This benchmark facility integrates cutting-edge equipment and technologies from more than 50 world-leading suppliers across over ten countries, including Germany, the UK, the US, France, the Netherlands, Denmark, Switzerland, and Finland. It is now one of the world's most advanced facilities in terms of scale, technology, and digitalization.

Yili's Infant Formula Manufacturing Facility. [Photo provided to chinadaily.com.cn]

Yili has maintained a long-term focus on maternal and infant nutrition research, accumulating over 10 million data points on breast milk composition and holding more than 290 invention patents.

Yili and Mannings sign a strategic partnership agreement at the launching ceremony. [Photo provided to chinadaily.com.cn]